PharmaBoardroom

Prof. Dr. med. Adriano Aguzzi provides insight on the past, present, and future of prion and antibody therapy research in Switzerland. The Institute…

Professor Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) emphasizes the importance of partnerships and sharing…

This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of employees by region, investment…

Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and…

The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and…

The executive director of A*STAR’s Biomedical Research Council, Dr. Benjamin Seet highlights several remarkable milestones that the organization has…

France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to thrive in terms of the industry's…

The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have…

The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing plants, to investments and export…

Professor Dr. Susan M. Gasser of the Friedrich Miescher Institute for Biomedical Research describes FMI’s fundamental connection between academia…

Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active…

Known as “Ireland’s university of Enterprise,” Dublin City University’s research and educational philosophy is very much informed by the…